• Explore /
  • Poster
  • / Activity of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) in patients (pts) with NSCLC with uncommon <em>EGFR</em> mutations: A real-world cohort study (UpSwinG).

Activity of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) in patients (pts) with NSCLC with uncommon EGFR mutations: A real-world cohort study (UpSwinG).

Abstract Video & Slides Poster

Authors

null

Satoru Miura

Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan

Satoru Miura , Te-Chun Hsia , Jen-Yu Hung , Hyun Ae Jung , Jin-Yuan Shih , Cheol-Kyu Park , Seung Hyeun Lee , Tatsuro Okamoto , Hee Kyung Ahn , Yong Chul Lee , Yuki Sato , Sung Sook Lee , Celine Mascaux , Hasan Daoud , Angela Maerten , Sanjay Popat

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT04179890

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 9072)

DOI

10.1200/JCO.2021.39.15_suppl.9072

Abstract #

9072

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Chuan Lu

First Author: Kiyoaki Uryu

First Author: Min Hee Hong

First Author: Xiuning Le